Antiplatelet Therapy for the Prevention of Ischemic Events in ACS
Online pmiCME Patient Case Study
Horizon CME partners with pmiCME to produce online patient case study activities. These cases are physician-authored, interactive and include everything from initial findings and diagnosis to treatment and follow-up.
Click here for full activity description and participation information
Topics
Cardiology, Hypertension, and Vascular Disorders
Expiration Date
July 22, 2011
Primary Audience
Cardiologists
Credits
2 AMA PRA Category 1 Credits™
Author
Christopher Cannon, MD,
Senior Investigator, TIMI Study Group/Brigham & Women’s Hospital,
Boston, Massachusetts
Learning Objectives
- Describe current guideline recommendations for the use of antiplatelet therapies in the management ACS patients, including the implications of the latest STEMI guidelines on clinical practice.
- Apply research data on antiplatelet therapy in ACS patients as it relates to genetic polymorphism, and discuss the latest evidence on concomitant use of thienopyridines and proton pump inhibitors.
Cost
Complementary
Grant Support
This activity is supported by an educational grant from the Bristol-Myers Squibb/sanofi Pharmaceuticals Partnership.
Access to Case
The activity is hosted on the Pri-Med website and a can be accessed by clicking on the following link:
http://www.pri-med.com/PMO/Activity.aspx?activity=110990